Found: 24
Select item for more details and to access through your institution.
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1301, doi. 10.1002/ajh.25238
- By:
- Publication type:
- Article
Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2002, v. 71, n. 3, p. 166, doi. 10.1002/ajh.10209
- By:
- Publication type:
- Article
MAGIC‐DR: An interpretable machine‐learning guided approach for acute myeloid leukemia measurable residual disease analysis.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 239, doi. 10.1002/cyto.b.22168
- By:
- Publication type:
- Article
Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. E36, doi. 10.3816/CLM.2009.n.098
- By:
- Publication type:
- Article
Glasdegib with LDAC in Newly Diagnosed Patients with Acute Myeloid Leukemia (AML) Unsuitable for Intensive Chemotherapy: Effects on Transfusions and Marrow Recovery vs LDAC Alone.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S230, doi. 10.1016/j.clml.2019.07.114
- By:
- Publication type:
- Article
Clinical Benefit of Glasdegib Plus Low-Dose Cytarabine in Patients with De Novo and Secondary Acute Myeloid Leukemia: Long-Term Analysis of a Phase 2 Randomized Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S231, doi. 10.1016/j.clml.2019.07.116
- By:
- Publication type:
- Article
Low-Dose Cytarabine With or Without Glasdegib in Newly Diagnosed Patients with Acute Myeloid Leukemia: Long-Term Analysis of a Phase 2 Randomized Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S228, doi. 10.1016/j.clml.2019.07.111
- By:
- Publication type:
- Article
Global research priorities for social, behavioural and community engagement interventions for maternal, newborn and child health.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00929-8
- By:
- Publication type:
- Article
Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 3, p. 349, doi. 10.1002/jcph.1742
- By:
- Publication type:
- Article
Retrobulbar axonal degeneration due to optic disc drusen.
- Published in:
- Clinical & Experimental Ophthalmology, 2018, v. 46, n. 5, p. 564, doi. 10.1111/ceo.13137
- By:
- Publication type:
- Article
Malaria Screening Using Front-Line Loop-Mediated Isothermal Amplification.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Perceptual Models for Speech, Audio, and Music Processing.
- Published in:
- EURASIP Journal on Audio Speech & Music Processing, 2007, v. 2007, p. 1, doi. 10.1155/2007/12687
- By:
- Publication type:
- Article
Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 4, p. 451, doi. 10.1007/s00280-020-04132-x
- By:
- Publication type:
- Article
Tuberculosis Case Finding in Kulon Progo District, Yogyakarta, Indonesia: Passive versus Active Case Finding Using Mobile Chest X-ray.
- Published in:
- Tropical Medicine & Infectious Disease, 2024, v. 9, n. 4, p. 75, doi. 10.3390/tropicalmed9040075
- By:
- Publication type:
- Article
The Yield of Active Tuberculosis Disease and Latent Tuberculosis Infection in Tuberculosis Household Contacts Investigated Using Chest X-ray in Yogyakarta Province, Indonesia.
- Published in:
- Tropical Medicine & Infectious Disease, 2024, v. 9, n. 2, p. 34, doi. 10.3390/tropicalmed9020034
- By:
- Publication type:
- Article
High Tuberculosis Preventive Treatment Uptake and Completion Rates Using a Person-Centered Approach among Tuberculosis Household Contact in Yogyakarta.
- Published in:
- Tropical Medicine & Infectious Disease, 2023, v. 8, n. 12, p. 520, doi. 10.3390/tropicalmed8120520
- By:
- Publication type:
- Article
Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons.
- Published in:
- ClinicoEconomics & Outcomes Research, 2019, v. 11, p. 551, doi. 10.2147/CEOR.S203482
- By:
- Publication type:
- Article
Assessment of the effect of ofatumumab on cardiac repolarization.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 1, p. 114, doi. 10.1002/jcph.376
- By:
- Publication type:
- Article
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 8, p. 1689, doi. 10.1007/s00277-022-04853-4
- By:
- Publication type:
- Article
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase I study of glasdegib ( PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies.
- Published in:
- Cancer Science, 2017, v. 108, n. 8, p. 1628, doi. 10.1111/cas.13285
- By:
- Publication type:
- Article